Published in J Virol on February 08, 2012
Architecture of respiratory syncytial virus revealed by electron cryotomography. Proc Natl Acad Sci U S A (2013) 1.51
Respiratory syncytial virus: virology, reverse genetics, and pathogenesis of disease. Curr Top Microbiol Immunol (2013) 1.01
The comparative genomics of human respiratory syncytial virus subgroups A and B: genetic variability and molecular evolutionary dynamics. J Virol (2013) 1.01
Respiratory syncytial virus G protein CX3C motif impairs human airway epithelial and immune cell responses. J Virol (2013) 0.92
Paramyxovirus glycoprotein incorporation, assembly and budding: a three way dance for infectious particle production. Viruses (2014) 0.89
Structural analysis of respiratory syncytial virus reveals the position of M2-1 between the matrix protein and the ribonucleoprotein complex. J Virol (2014) 0.89
Respiratory Syncytial Virus Uses CX3CR1 as a Receptor on Primary Human Airway Epithelial Cultures. PLoS Pathog (2015) 0.89
Combining single RNA sensitive probes with subdiffraction-limited and live-cell imaging enables the characterization of virus dynamics in cells. ACS Nano (2013) 0.87
The respiratory syncytial virus fusion protein targets to the perimeter of inclusion bodies and facilitates filament formation by a cytoplasmic tail-dependent mechanism. J Virol (2013) 0.87
Respiratory syncytial virus assembles into structured filamentous virion particles independently of host cytoskeleton and related proteins. PLoS One (2012) 0.87
CX3CR1 is an important surface molecule for respiratory syncytial virus infection in human airway epithelial cells. J Gen Virol (2015) 0.85
Evidence for the interaction of the human metapneumovirus G and F proteins during virus-like particle formation. Virol J (2013) 0.84
The Thr205 phosphorylation site within respiratory syncytial virus matrix (M) protein modulates M oligomerization and virus production. J Virol (2014) 0.84
New host factors important for respiratory syncytial virus (RSV) replication revealed by a novel microfluidics screen for interactors of matrix (M) protein. Mol Cell Proteomics (2015) 0.82
Dimerization of matrix protein is required for budding of respiratory syncytial virus. J Virol (2015) 0.82
Modulation of host adaptive immunity by hRSV proteins. Virulence (2014) 0.78
Molecular mechanisms driving respiratory syncytial virus assembly. Future Microbiol (2013) 0.77
Nipah Virus Matrix Protein Influences Fusogenicity and Is Essential for Particle Infectivity and Stability. J Virol (2015) 0.77
Mutating the CX3C Motif in the G Protein Should Make a Live Respiratory Syncytial Virus Vaccine Safer and More Effective. J Virol (2017) 0.75
The Respiratory Syncytial Virus Phosphoprotein, Matrix Protein, and Fusion Protein Carboxy-Terminal Domain Drive Efficient Filamentous Virus-Like Particle Formation. J Virol (2016) 0.75
Host cytoskeleton in respiratory syncytial virus assembly and budding. Virol J (2016) 0.75
RSV glycoprotein and genomic RNA dynamics reveal filament assembly prior to the plasma membrane. Nat Commun (2017) 0.75
Protective role of Indoleamine 2,3 dioxygenase in Respiratory Syncytial Virus associated immune response in airway epithelial cells. Virology (2017) 0.75
Codon usage limitation in the expression of HIV-1 envelope glycoprotein. Curr Biol (1996) 4.52
Nucleotide sequence of the gene encoding the fusion (F) glycoprotein of human respiratory syncytial virus. Proc Natl Acad Sci U S A (1984) 3.42
Measles viruses with altered envelope protein cytoplasmic tails gain cell fusion competence. J Virol (1998) 3.27
Demonstration that glycoprotein G is the attachment protein of respiratory syncytial virus. J Gen Virol (1987) 2.79
Mechanisms for enveloped virus budding: can some viruses do without an ESCRT? Virology (2007) 2.68
Respiratory syncytial virus pneumonia among the elderly: an assessment of disease burden. J Infect Dis (1999) 2.44
Noncytopathic replication of Venezuelan equine encephalitis virus and eastern equine encephalitis virus replicons in Mammalian cells. J Virol (2005) 2.00
Identification of the respiratory syncytial virus proteins required for formation and passage of helper-dependent infectious particles. J Virol (1998) 1.95
Characterization of the 10 proteins of human respiratory syncytial virus: identification of a fourth envelope-associated protein. Virus Res (1985) 1.82
Escaping from the cell: assembly and budding of negative-strand RNA viruses. Curr Top Microbiol Immunol (2004) 1.77
Respiratory syncytial virus matures at the apical surfaces of polarized epithelial cells. J Virol (1995) 1.73
Respiratory viral infections in immunocompetent and immunocompromised persons. Am J Med (1997) 1.73
Analysis of respiratory syncytial virus F, G, and SH proteins in cell fusion. Virology (1994) 1.72
Identification of nucleolin as a cellular receptor for human respiratory syncytial virus. Nat Med (2011) 1.70
Molecular mechanism of paramyxovirus budding. Virus Res (2004) 1.65
Role of cellular actin in the gene expression and morphogenesis of human respiratory syncytial virus. Virology (1998) 1.60
Respiratory syncytial virus uses a Vps4-independent budding mechanism controlled by Rab11-FIP2. Proc Natl Acad Sci U S A (2008) 1.55
Morphogenesis of respiratory syncytial virus in a green monkey kidney cell line (Vero). J Virol (1970) 1.53
Morphogenesis and ultrastructure of respiratory syncytial virus. J Virol (1973) 1.48
Paramyxovirus assembly and budding: building particles that transmit infections. Int J Biochem Cell Biol (2010) 1.44
Cooperativity of actin and microtubule elements during replication of respiratory syncytial virus. Virology (2005) 1.42
RhoA signaling is required for respiratory syncytial virus-induced syncytium formation and filamentous virion morphology. J Virol (2005) 1.36
Apical recycling systems regulate directional budding of respiratory syncytial virus from polarized epithelial cells. Proc Natl Acad Sci U S A (2003) 1.33
Role of plasma membrane lipid microdomains in respiratory syncytial virus filament formation. J Virol (2003) 1.33
Dynamics of filamentous viral RNPs prior to egress. Nucleic Acids Res (2007) 1.30
Protein analysis of purified respiratory syncytial virus particles reveals an important role for heat shock protein 90 in virus particle assembly. Mol Cell Proteomics (2010) 1.27
Respiratory syncytial virus matrix protein associates with nucleocapsids in infected cells. J Gen Virol (2002) 1.24
Sorting of the respiratory syncytial virus matrix protein into detergent-resistant structures is dependent on cell-surface expression of the glycoproteins. Virology (2002) 1.23
Association of respiratory syncytial virus M protein with viral nucleocapsids is mediated by the M2-1 protein. J Virol (2008) 1.21
Caveolin-1 is incorporated into mature respiratory syncytial virus particles during virus assembly on the surface of virus-infected cells. J Gen Virol (2002) 1.20
The cytoplasmic tail of the human respiratory syncytial virus F protein plays critical roles in cellular localization of the F protein and infectious progeny production. J Virol (2006) 1.20
The small hydrophobic (SH) protein accumulates within lipid-raft structures of the Golgi complex during respiratory syncytial virus infection. J Gen Virol (2004) 1.19
Interaction between the respiratory syncytial virus G glycoprotein cytoplasmic domain and the matrix protein. J Gen Virol (2005) 1.19
Structural characterization of respiratory syncytial virus fusion inhibitor escape mutants: homology model of the F protein and a syncytium formation assay. Virology (2003) 1.17
Ultrastructural analysis of the interaction between F-actin and respiratory syncytial virus during virus assembly. Virology (2007) 1.16
Interactions between cellular actin and human respiratory syncytial virus (HRSV). Virus Res (1998) 1.11
Analysis of the interaction between respiratory syncytial virus and lipid-rafts in Hep2 cells during infection. Virology (2004) 1.11
Distribution of the attachment (G) glycoprotein and GM1 within the envelope of mature respiratory syncytial virus filaments revealed using field emission scanning electron microscopy. Virology (2003) 1.10
A new Sendai virus vector deficient in the matrix gene does not form virus particles and shows extensive cell-to-cell spreading. J Virol (2003) 1.10
The matrix protein of Human respiratory syncytial virus localises to the nucleus of infected cells and inhibits transcription. Arch Virol (2003) 1.08
The transmembrane domain of the respiratory syncytial virus F protein is an orientation-independent apical plasma membrane sorting sequence. J Virol (2005) 1.08
Human respiratory syncytial virus matrix protein is an RNA-binding protein: binding properties, location and identity of the RNA contact residues. J Gen Virol (2004) 1.07
Surface features of a Mononegavirales matrix protein indicate sites of membrane interaction. Proc Natl Acad Sci U S A (2009) 1.05
Infectivity of a human respiratory syncytial virus lacking the SH, G, and F proteins is efficiently mediated by the vesicular stomatitis virus G protein. J Virol (2003) 1.05
Profilin is required for viral morphogenesis, syncytium formation, and cell-specific stress fiber induction by respiratory syncytial virus. BMC Microbiol (2003) 1.03
Central role of the respiratory syncytial virus matrix protein in infection. FEMS Microbiol Rev (2006) 0.99
Scanning electron microscopical demonstration of respiratory syncytial virus antigens by immunological markers. J Ultrastruct Res (1975) 0.98
The baculovirus GP64 protein mediates highly stable infectivity of a human respiratory syncytial virus lacking its homologous transmembrane glycoproteins. J Virol (2004) 0.97
Suppression of the Sendai virus M protein through a novel short interfering RNA approach inhibits viral particle production but does not affect viral RNA synthesis. J Virol (2006) 0.94
Chimeric bovine respiratory syncytial virus with attachment and fusion glycoproteins replaced by bovine parainfluenza virus type 3 hemagglutinin-neuraminidase and fusion proteins. J Virol (2001) 0.93
Influence of lipids on the interfacial disposition of respiratory syncytical virus matrix protein. Langmuir (2010) 0.92
Human respiratory syncytial virus glycoproteins are not required for apical targeting and release from polarized epithelial cells. J Virol (2008) 0.91
trans-Complementation allows recovery of human respiratory syncytial viruses that are infectious but deficient in cell-to-cell transmission. J Virol (2004) 0.88
Use of a novel cell-based fusion reporter assay to explore the host range of human respiratory syncytial virus F protein. Virol J (2005) 0.87
Progress towards control of the acute respiratory viral diseases of childhood. Bull World Health Organ (1987) 0.85
Requirements for Human Respiratory Syncytial Virus Glycoproteins in Assembly and Egress from Infected Cells. Adv Virol (2011) 0.82
Sequence and structure relatedness of matrix protein of human respiratory syncytial virus with matrix proteins of other negative-sense RNA viruses. Clin Microbiol Infect (2004) 0.79
MicroRNA-127 modulates fetal lung development. Physiol Genomics (2009) 1.68
The effect of strawberries in a cholesterol-lowering dietary portfolio. Metabolism (2008) 0.97
Respiratory syncytial virus G protein CX3C motif impairs human airway epithelial and immune cell responses. J Virol (2013) 0.92
Human respiratory syncytial virus glycoproteins are not required for apical targeting and release from polarized epithelial cells. J Virol (2008) 0.91
The stability of human respiratory syncytial virus is enhanced by incorporation of the baculovirus GP64 protein. Vaccine (2007) 0.88
The respiratory syncytial virus fusion protein targets to the perimeter of inclusion bodies and facilitates filament formation by a cytoplasmic tail-dependent mechanism. J Virol (2013) 0.87
Key developmental transitions in human germinal center B cells are revealed by differential CD45RB expression. Blood (2008) 0.83
Ionotropic GABA receptor expression in the lung during development. Gene Expr Patterns (2008) 0.82
What motivates general practitioners to teach? Clin Teach (2014) 0.81
CD45RO enriches for activated, highly mutated human germinal center B cells. Blood (2007) 0.78
Consumption of a dietary portfolio of cholesterol lowering foods improves blood lipids without affecting concentrations of fat soluble compounds. Nutr J (2014) 0.76